Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

commercialisation

- PMLiVE

Patient disengagement

Understanding the why

- PMLiVE

The patient’s world is ‘messy’

And therein lies the value for pharma

Price matters

But so does innovation

Breathing data

Novartis’ new CEO-designate points to an evolutionary leap

- PMLiVE

After failing to repeal Obamacare, Trump tries another tack

US president signs executive order encouraging cheaper policies with fewer benefits

Brexit implications for UK pharma legislation

What are the potential options and outcomes of the negotiations?

- PMLiVE

Macron, Merkel and May: implications of the 2017 elections for the life science industry

Political instability and policy continuity in Europe’s biggest economies mean a worsening commercial environment stacked with uncertainty

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Signal strength

Communications that connect

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Anthill Agency

- PMLiVE

Real-world evidence

Have we come full-circle?

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links